We demonstrated the obvious expression of IDO1 and IDO2, a more recently identified novel isoform of IDO, at the human maternal–fetal interface at seven weeks of gestation obtained from hysterectomy for cervical cancer with a pregnancy in situ. This evidence concerns the gene IDO2 and cervical carcinoma.